Stammdaten
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. The company is developing five products, including JI MAI—bovine cardiac vascular active peptide; cartilage peptide, a type II collagen peptide; and Double Proline AG 3D active collagen peptide, as well as DNA repair tablets and sugar master tablets. The company was incorporated in 2019 and is based in Twinsburg, Ohio.
Unternehmen & Branche
| Name | GOLDENWELL BIOTECH, INC. |
|---|---|
| Ticker | GWLL |
| CIK | 0001800373 |
| Boerse | US |
| Sektor | Consumer Defensive |
| Industrie | Packaged Foods |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 99,0 Mio. USD |
| Beta | 6,81 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-09-30 | 10-Q | 0 | -7,985 | 220,410 | -94,823 | |
| 2025-06-30 | 10-Q | 0 | -5,220 | 251,295 | -86,838 | |
| 2025-03-31 | 10-Q | 0 | -34,376 | 0.00 | 191,915 | -81,618 |
| 2024-12-31 | 10-K | 139 | -131,498 | 0.00 | 224,192 | -47,241 |
| 2024-09-30 | 10-Q | 0 | 23,065 | 179,432 | 19,239 | |
| 2024-06-30 | 10-Q | 139 | 49,920 | 200,398 | 3,826 | |
| 2024-03-31 | 10-Q | 0 | 30,977 | 0.00 | 198,968 | 53,746 |
| 2023-12-31 | 10-Q | -20,799 | 228,057 | 84,723 | ||
| 2023-12-31 | 10-K | 1,836 | -20,799 | 0.00 | 228,094 | 84,257 |
| 2023-09-30 | 10-Q | 382 | -35,406 | 186,933 | 105,522 | |
| 2023-09-30 | 10-K | -35,406 | 105,522 | |||
| 2023-06-30 | 10-Q | 276 | -27,084 | 192,339 | 140,929 | |
| 2023-06-30 | 10-K | -27,084 | 140,929 | |||
| 2023-03-31 | 10-Q | 1,422 | -33,606 | 219,422 | 168,012 | |
| 2023-03-31 | 10-K | -33,606 | 168,012 | |||
| 2022-12-31 | 10-K | 0 | -920,332 | 248,400 | 201,618 | |
| 2022-12-31 | 10-Q | -920,332 | 248,400 | 201,618 | ||
| 2022-09-30 | 10-Q | 43,690 | -4,584 | 266,077 | 236,950 | |
| 2022-09-30 | 10-K | -4,584 | 236,950 | |||
| 2022-06-30 | 10-Q | 3,713 | -26,800 | 274,400 | 241,533 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.